BioSpace News Archive

Fresenius Kabi announced today it has received FDA approval for Daptomycin for Injection and the product is available immediately for customers in the United States

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2018 after the market closes on Wednesday, April 25, 2018.

Pharnext SA reported its financial and operational results for the year ended December 31, 2017.

Designed to educate and activate physicians and potential patients worldwide in the fight against the growing liver disease known as Nonalcoholic Steatohepatitis (NASH), The NASH Education Program[TM] today expands its global breadth and depth, adding powerful new patient advocacy partners and collaborators from biotechnology as supporters of the 1st international NASH Day.

Sectra announces that the nationwide telepathology solution in the Netherlands is now ready for use by the country’s pathology labs.

Enterprise Therapeutics Ltd announced that it has closed an oversubscribed £29 million ($41 million USD) Series B round co-led by Versant Ventures and Novartis Venture Fund.

The world’s most talented innovation leaders were honored for their tireless contributions in launching new products that will change the world in the fields of Science and Medical, Robotics, Energy and Sustainability, Commercial Safety and the future of Space Travel.

Zeel launches its Massage On Demand® service today in Richmond, Virginia.

By modifying prescription drug opioids into an oral thin film delivery strip, RSCI believes it can reduce the abuse by preventing users from crushing the pills for addictive use through IV self-injections, inhalation through combustible methods such as a cigarette or nasal abuse similar to cocaine.

Conventus Orthopaedics announced the appointment of Jonathan Isenburg as its new Chief Financial Officer.